The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

23 articles for AD Mesecar


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators.EBI
University of Illinois At Chicago
Structure-based design, synthesis and biological evaluation of novelß-secretase inhibitors containing a pyrazole or thiazole moiety as the P3 ligand.EBI
Purdue University
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases.EBI
Purdue University
Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase.EBI
Purdue University
Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.EBI
Purdue University
Synthesis of novel¿¿3 receptor ligands via an unusual Knoevenagel condensation.EBI
Moscow State University
Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.EBI
Purdue University
Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase.EBI
University of Illinois At Chicago
Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.EBI
Purdue University
Potential chemopreventive agents based on the structure of the lead compound 2-bromo-1-hydroxyphenazine, isolated from Streptomyces species, strain CNS284.EBI
Purdue University
Bioactive compounds from the fern Lepisorus contortus.EBI
Yunnan Normal University
Exploration of P1 and P4 modifications of nirmatrelvir: Design, synthesis, biological evaluation, and X-ray structural studies of SARS-CoV-2 Mpro inhibitors.EBI
Purdue University
SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads.EBI
Purdue University
Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors.EBI
Purdue University
Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors.EBI
Purdue University
Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand.EBI
Purdue University
Design, synthesis, and X-ray structural studies of BACE-1 inhibitors containing substituted 2-oxopiperazines as P1'-P2' ligands.EBI
Purdue University
Pyrazole compounds substituted with heteroaryl and pharmaceutical use thereofBDB
Japan Tobacco
Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitorsBDB
Bayer Pharma Aktiengesellschaft
Ectonucleotidase inhibitors and methods of use thereofBDB
Calithera Biosciences
Metabolism probes for therapy and diagnosisBDB
Vanderbilt University
Oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infectionBDB
Hoffmann-La Roche
Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors.BDB
Bristol-Myers Squibb Pharmaceutical Research Institute